Cargando…

Effervescent Atomizer as Novel Cell Spray Technology to Decrease the Gas-to-Liquid Ratio

Cell spraying has become a feasible application method for cell therapy and tissue engineering approaches. Different devices have been used with varying success. Often, twin-fluid atomizers are used, which require a high gas velocity for optimal aerosolization characteristics. To decrease the amount...

Descripción completa

Detalles Bibliográficos
Autores principales: Thiebes, Anja Lena, Klein, Sarah, Zingsheim, Jonas, Möller, Georg H., Gürzing, Stefanie, Reddemann, Manuel A., Behbahani, Mehdi, Jockenhoevel, Stefan, Cornelissen, Christian G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697195/
https://www.ncbi.nlm.nih.gov/pubmed/36365239
http://dx.doi.org/10.3390/pharmaceutics14112421
_version_ 1784838500304027648
author Thiebes, Anja Lena
Klein, Sarah
Zingsheim, Jonas
Möller, Georg H.
Gürzing, Stefanie
Reddemann, Manuel A.
Behbahani, Mehdi
Jockenhoevel, Stefan
Cornelissen, Christian G.
author_facet Thiebes, Anja Lena
Klein, Sarah
Zingsheim, Jonas
Möller, Georg H.
Gürzing, Stefanie
Reddemann, Manuel A.
Behbahani, Mehdi
Jockenhoevel, Stefan
Cornelissen, Christian G.
author_sort Thiebes, Anja Lena
collection PubMed
description Cell spraying has become a feasible application method for cell therapy and tissue engineering approaches. Different devices have been used with varying success. Often, twin-fluid atomizers are used, which require a high gas velocity for optimal aerosolization characteristics. To decrease the amount and velocity of required air, a custom-made atomizer was designed based on the effervescent principle. Different designs were evaluated regarding spray characteristics and their influence on human adipose-derived mesenchymal stromal cells. The arithmetic mean diameters of the droplets were 15.4–33.5 µm with decreasing diameters for increasing gas-to-liquid ratios. The survival rate was >90% of the control for the lowest gas-to-liquid ratio. For higher ratios, cell survival decreased to approximately 50%. Further experiments were performed with the design, which had shown the highest survival rates. After seven days, no significant differences in metabolic activity were observed. The apoptosis rates were not influenced by aerosolization, while high gas-to-liquid ratios caused increased necrosis levels. Tri-lineage differentiation potential into adipocytes, chondrocytes, and osteoblasts was not negatively influenced by aerosolization. Thus, the effervescent aerosolization principle was proven suitable for cell applications requiring reduced amounts of supplied air. This is the first time an effervescent atomizer was used for cell processing.
format Online
Article
Text
id pubmed-9697195
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96971952022-11-26 Effervescent Atomizer as Novel Cell Spray Technology to Decrease the Gas-to-Liquid Ratio Thiebes, Anja Lena Klein, Sarah Zingsheim, Jonas Möller, Georg H. Gürzing, Stefanie Reddemann, Manuel A. Behbahani, Mehdi Jockenhoevel, Stefan Cornelissen, Christian G. Pharmaceutics Article Cell spraying has become a feasible application method for cell therapy and tissue engineering approaches. Different devices have been used with varying success. Often, twin-fluid atomizers are used, which require a high gas velocity for optimal aerosolization characteristics. To decrease the amount and velocity of required air, a custom-made atomizer was designed based on the effervescent principle. Different designs were evaluated regarding spray characteristics and their influence on human adipose-derived mesenchymal stromal cells. The arithmetic mean diameters of the droplets were 15.4–33.5 µm with decreasing diameters for increasing gas-to-liquid ratios. The survival rate was >90% of the control for the lowest gas-to-liquid ratio. For higher ratios, cell survival decreased to approximately 50%. Further experiments were performed with the design, which had shown the highest survival rates. After seven days, no significant differences in metabolic activity were observed. The apoptosis rates were not influenced by aerosolization, while high gas-to-liquid ratios caused increased necrosis levels. Tri-lineage differentiation potential into adipocytes, chondrocytes, and osteoblasts was not negatively influenced by aerosolization. Thus, the effervescent aerosolization principle was proven suitable for cell applications requiring reduced amounts of supplied air. This is the first time an effervescent atomizer was used for cell processing. MDPI 2022-11-09 /pmc/articles/PMC9697195/ /pubmed/36365239 http://dx.doi.org/10.3390/pharmaceutics14112421 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Thiebes, Anja Lena
Klein, Sarah
Zingsheim, Jonas
Möller, Georg H.
Gürzing, Stefanie
Reddemann, Manuel A.
Behbahani, Mehdi
Jockenhoevel, Stefan
Cornelissen, Christian G.
Effervescent Atomizer as Novel Cell Spray Technology to Decrease the Gas-to-Liquid Ratio
title Effervescent Atomizer as Novel Cell Spray Technology to Decrease the Gas-to-Liquid Ratio
title_full Effervescent Atomizer as Novel Cell Spray Technology to Decrease the Gas-to-Liquid Ratio
title_fullStr Effervescent Atomizer as Novel Cell Spray Technology to Decrease the Gas-to-Liquid Ratio
title_full_unstemmed Effervescent Atomizer as Novel Cell Spray Technology to Decrease the Gas-to-Liquid Ratio
title_short Effervescent Atomizer as Novel Cell Spray Technology to Decrease the Gas-to-Liquid Ratio
title_sort effervescent atomizer as novel cell spray technology to decrease the gas-to-liquid ratio
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697195/
https://www.ncbi.nlm.nih.gov/pubmed/36365239
http://dx.doi.org/10.3390/pharmaceutics14112421
work_keys_str_mv AT thiebesanjalena effervescentatomizerasnovelcellspraytechnologytodecreasethegastoliquidratio
AT kleinsarah effervescentatomizerasnovelcellspraytechnologytodecreasethegastoliquidratio
AT zingsheimjonas effervescentatomizerasnovelcellspraytechnologytodecreasethegastoliquidratio
AT mollergeorgh effervescentatomizerasnovelcellspraytechnologytodecreasethegastoliquidratio
AT gurzingstefanie effervescentatomizerasnovelcellspraytechnologytodecreasethegastoliquidratio
AT reddemannmanuela effervescentatomizerasnovelcellspraytechnologytodecreasethegastoliquidratio
AT behbahanimehdi effervescentatomizerasnovelcellspraytechnologytodecreasethegastoliquidratio
AT jockenhoevelstefan effervescentatomizerasnovelcellspraytechnologytodecreasethegastoliquidratio
AT cornelissenchristiang effervescentatomizerasnovelcellspraytechnologytodecreasethegastoliquidratio